Our study expands the mutation spectrum of COL7A1 and demonstrated that clinical exome sequencing and minigene assays were efficient tools for recessive dystrophic epidermolysis bullosa molecular diagnoses. Here, COL7A1 is linked to epidermolysis bullosa.